⌘K

Home/Filings/SC 13D/A/0001072613-21-000655

SC 13D/A//SEC Filing

Trillium Therapeutics Inc. SC 13D/A

Accession 0001072613-21-000655

CIK 0001616212operating

View on SEC.gov Company Profile

Filed

Nov 18, 7:00 PM ET

Accepted

Nov 19, 6:44 AM ET

Size

104.7 KB

Accession

0001072613-21-000655

Documents

1 file

SC
geo5_18561.htm
GROWTH EQUITY OPPORTUNITIES FUND V, LLC - TRILLIUM THERAPEUTICS -- SCHEDULE 13D/A5E

Issuer

Trillium Therapeutics Inc.

CIK 0001616212

Entity typeoperating

IncorporatedBritish Columbia, Canada

Related Parties

1

filerCIK 0001616212

Filing Metadata

Form type: SC 13D/A
Filed: Nov 18, 7:00 PM ET
Accepted: Nov 19, 6:44 AM ET
Size: 104.7 KB

View on SEC.gov